Clinical Analysis of Weijin Xiaoyong Decoction in Adjuvant Therapy of Bronchiectasis at Acute Exacerbation Stage with Syndrome of Phlegm-heat Obstructing Lung
|更新时间:2024-09-23
|
Clinical Analysis of Weijin Xiaoyong Decoction in Adjuvant Therapy of Bronchiectasis at Acute Exacerbation Stage with Syndrome of Phlegm-heat Obstructing Lung
Chinese Journal of Experimental Traditional Medical FormulaeVol. 22, Issue 15, Pages: 194-198(2016)
FANG Bo, ZHAO Gang. Clinical Analysis of Weijin Xiaoyong Decoction in Adjuvant Therapy of Bronchiectasis at Acute Exacerbation Stage with Syndrome of Phlegm-heat Obstructing Lung[J]. Chinese journal of experimental traditional medical formulae, 2016, 22(15): 194-198.
DOI:
FANG Bo, ZHAO Gang. Clinical Analysis of Weijin Xiaoyong Decoction in Adjuvant Therapy of Bronchiectasis at Acute Exacerbation Stage with Syndrome of Phlegm-heat Obstructing Lung[J]. Chinese journal of experimental traditional medical formulae, 2016, 22(15): 194-198. DOI: 10.13422/j.cnki.syfjx.2016150194.
Clinical Analysis of Weijin Xiaoyong Decoction in Adjuvant Therapy of Bronchiectasis at Acute Exacerbation Stage with Syndrome of Phlegm-heat Obstructing Lung
Objective: To observe the efficacy of Weijin Xiaoyong decoction in the adjuvant therapy of bronchiectasis at acute exacerbation stage with syndrome of phlegm-heat obstructing lung
and investigate its effects on levels of matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of metalloproteinase-1 (TIMP-1) in serum and sputum. Method: Ninty-eight patients with acute exacerbation stage bronchiectasis were randomly divided into treatment group (49 cases) and control group (49 cases) according to random number table. Non-pharmaceutical interventions were given according to ‘Expert Consensus on Diagnosis and Treatment of Adult Bronchiectasis Disease’ in both groups. In the control group
0.4 g ofloxacin hydrochloride injection was added to 400 mL normal saline for anti-infection (200 mL/time
bid)
0.6 g ofloxacin hydrochloride injection was added to 600 mL normal saline for pseudomonas aeruginosa infection (300 mL/time
bid)
30 mg ambroxol injection was added to 100 mL normal saline for dissipating phlegm
qd. The patients in treatment group also received Weijin Xiaoyong decoction (one dose/day
boiled and taken orally twice) based on the treatment in control group. The treatment course was 2 weeks for both groups. Forced expiratory volume in one second (FEV1)
FEV1/forced vital capacity (FVC)
blood oxygen partial pressure (PaO2)
CO2 partial pressure (PaCO2)
blood oxygen saturation (SaO2) and clinical symptom scores were compared between two groups. The clinical efficacy was analyzed in two groups. The levels of MMP-9 and TIMP-1 in serum and sputum were detected in both groups. Result: After treatment
FEV1
FEV1/FVC
PaO2 and SaO2 levels in treatment group were significantly higher than those in control group
while clinical scores such as PaCO2 and cough were significantly lower than those in control one (P<0.01). The total effective rate was 95.92%in treatment group
significantly higher than 79.59%in control group (P<0.05). After treatment
the levels of MMP-9 in serum and sputum in treatment group were significantly lower than those in control group
while TIMP-1 levels were higher than those of control group (P<0.01). Conclusion: Weijin Xiaoyong decoction based on the routine western medicine
has an exact effect in the adjuvant therapy of bronchiectasis at acute exacerbation stage with syndrome of phlegm-heat obstructing lung
and the mechanism may be associated with down-regulating MMP-9 levels in serum and sputum
Effect of Modified Zhenwutang on Interstitial Fibrosis in Rats with Chronic Renal Failure Based on IL-6/MMP-9/COL-Ⅳ Signaling Pathway
Clinical Efficacy of Modified Qingqi Huatan Wan in Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Syndrome of Phlegm-heat Obstructing Lung and Effect on Serum TNF-α, IL-8 and MMP-9
Influence of Tanyu Tongzhi Formula on Stability of Atherosclerotic Vulnerable Plaque of Carotid Artery in Rats
Clinical Study on Combined Therapy of Traditional Chinese and Western Medicine for Pneumonia Cough by a Multicenter Clinical Trial
Related Author
GUO Dengzhou
WANG Xin'ai
JIN Peipei
ZHANG Yuanyuan
LI Wanzhe
Ti-bao HOU
Jia HE
Chuan-dong YE
Related Institution
Graduate School, Hebei University of Chinese Medicine
The First Affiliated Hospital of Hebei University of Chinese Medicine,Hebei Provincial Hospital of Traditional Chinese Medicine
Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine
Nanyang Medical College
ZHANG Zhong-jing College of Traditional Chinese Medicine of Nanyang Institute of Technology